Méndez-Ferrer S, Bonnet D. Bone marrow niches in haematological malignancies. 2020;20:285–98.

Zhang N, Wu J, Wang Q, et al. Global burden of hematologic malignancies and evolution patterns over the past 30 years. Blood cancer J. 2023;13:82.

Article  PubMed  PubMed Central  Google Scholar 

Larsson SC, Wolk A. Obesity and risk of non-hodgkin’s lymphoma: a meta-analysis. Int J Cancer. 2007;121:1564–70.

Article  PubMed  CAS  Google Scholar 

Kamper-Jørgensen M, Rostgaard K, Glaser SL, et al. Cigarette smoking and risk of Hodgkin lymphoma and its subtypes: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph). Ann Oncol. 2013;24:2245–55.

Article  PubMed  PubMed Central  Google Scholar 

Agathocleous M, Meacham CE, Burgess RJ, et al. Ascorbate regulates haematopoietic stem cell function and leukaemogenesis. Nature. 2017;549:476–81.

Article  PubMed  PubMed Central  Google Scholar 

Saito Y, Chapple RH, Lin A, Kitano A, Nakada D. AMPK protects leukemia-initiating cells in myeloid leukemias from metabolic stress in the bone marrow. Cell Stem Cell. 2015;17:585–96.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lazaris V, Hatziri A, Symeonidis A, Kypreos KE. The Lipoprotein Transport System in the pathogenesis of multiple myeloma: advances and challenges. Front Oncol. 2021;11:638288.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Georgila K, Vyrla D, Drakos E. Apolipoprotein A-I (ApoA-I), immunity, inflammation and Cancer. Cancers (Basel) 2019;11.

Yavasoglu I, Sargin G, Yilmaz F, et al. Cholesterol levels in patients with chronic lymphocytic leukemia. J Natl Med Assoc. 2017;109:23–7.

PubMed  Google Scholar 

Usman H, Rashid R, Ameer F, et al. Revisiting the dyslipidemia associated with acute leukemia. Clin Chim Acta. 2015;444:43–9.

Article  PubMed  CAS  Google Scholar 

Ozturk E. The relationship between hematological malignancy and lipid Profile. Medeni Med J. 2021;36:146–51.

PubMed  PubMed Central  Google Scholar 

Mulas MF, Abete C, Pulisci D, et al. Cholesterol esters as growth regulators of lymphocytic leukaemia cells. Cell Prolif. 2011;44:360–71.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Fiorenza AM, Branchi A, Sommariva D. Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjects. Int J Clin Lab Res. 2000;30:141–5.

Article  PubMed  CAS  Google Scholar 

Halton JM, Nazir DJ, McQueen MJ, Barr RD. Blood lipid profiles in children with acute lymphoblastic leukemia. Cancer. 1998;83:379–84.

Article  PubMed  CAS  Google Scholar 

Baroni S, Scribano D, Zuppi C, Pagano L, Leone G, Giardina B. Prognostic relevance of lipoprotein cholesterol levels in acute lymphocytic and nonlymphocytic leukemia. Acta Haematol. 1996;96:24–8.

Article  PubMed  CAS  Google Scholar 

Cebi A, Akgun E, Esen R, Demir H, Cifci A. The activities of serum paraoxonase and arylesterase and lipid profile in acute myeloid leukemia: preliminary results. Eur Rev Med Pharmacol Sci. 2015;19:4590–4.

PubMed  CAS  Google Scholar 

Wang L, Chi PD, Chen H, Xiang J, Xia ZJ, Zhang YJ. Low level of high-density lipoprotein cholesterol correlates with poor prognosis in extranodal natural killer/T cell lymphoma. Tumour Biol. 2014;35:2141–9.

Article  PubMed  CAS  Google Scholar 

Yavasoglu I, Tombuloglu M, Kadikoylu G, Donmez A, Cagirgan S, Bolaman Z. Cholesterol levels in patients with multiple myeloma. Ann Hematol. 2008;87:223–8.

Article  PubMed  CAS  Google Scholar 

Kuliszkiewicz-Janus M, Malecki R, Mohamed AS. Lipid changes occuring in the course of hematological cancers. Cell Mol Biol Lett. 2008;13:465–74.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Naik PP, Ghadge MS, Raste AS. Lipid profile in leukemia and Hodgkin’s disease. Indian J Clin Biochem. 2006;21:100–2.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Goncalves RP, Rodrigues DG, Maranhao RC. Uptake of high density lipoprotein (HDL) cholesteryl esters by human acute leukemia cells. Leuk Res. 2005;29:955–9.

Article  PubMed  CAS  Google Scholar 

Loosen, S. H., Kostev, K., Luedde, M., Luedde, T. & Roderburg, C. Low blood levels of high-density lipoprotein (HDL) cholesterol are positively associated with cancer. J Cancer Res Clin Oncol 148, 3039-3046 (2022). https://doi.org/10.1007/s00432-021-03867-1

Fortuny J, Plana E, Kaye JA. Serum lipid trajectories in the years before a lymphoma diagnosis. Leuk Lymphoma. 2022;63:291–303.

Article  PubMed  CAS  Google Scholar 

Stocks T, Rapp K, Bjorge T, et al. Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts. PLoS Med. 2009;6:e1000201.

Article  PubMed  PubMed Central  Google Scholar 

Jung W, Jeon KH, Kang J et al. Association between Cholesterol Level and the risk of hematologic malignancy according to menopausal status: a Korean Nationwide Cohort Study. Biomedicines 2022;10.

Nagel G, Stocks T, Spath D, et al. Metabolic factors and blood cancers among 578,000 adults in the metabolic syndrome and cancer project (Me-Can). Ann Hematol. 2012;91:1519–31.

Article  PubMed  CAS  Google Scholar 

Pedersen KM, Çolak Y, Bojesen SE, Nordestgaard BG. Low high-density lipoprotein and increased risk of several cancers: 2 population-based cohort studies including 116,728 individuals. J Hematol Oncol. 2020;13:129.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jeong SM, Choi T, Kim D et al. Association between high-density lipoprotein cholesterol level and risk of hematologic malignancy. Leukemia. 2020.

Choi T, Choi IY, Han K et al. Lipid level, lipid variability, and risk of multiple myeloma: a Nationwide Population-based study of 3,527,776 subjects. Cancers 2021;13.

Guan XM, Wu SL, Yang XL, et al. Association of total cholesterol, low-density lipoprotein cholesterol, and non-high-density lipoprotein cholesterol with atherosclerotic cardiovascular disease and cancer in a Chinese male population. Int J Cancer. 2018;142:1209–17.

Article  PubMed  CAS  Google Scholar 

Jeong SM, Choi T, Kim D, et al. Association between high-density lipoprotein cholesterol level and risk of hematologic malignancy. Leukemia. 2021;35:1356–64.

Article  PubMed  CAS  Google Scholar 

Ahn J, Lim U, Weinstein SJ, et al. Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer. Cancer Epidemiol Biomarkers Prev. 2009;18:2814–21.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lim U, Gayles T, Katki HA, et al. Serum high-density lipoprotein cholesterol and risk of non-hodgkin lymphoma. Cancer Res. 2007;67:5569–74.

Article  PubMed  CAS  Google Scholar 

Walldius G, Malmström H, Jungner I, et al. Cohort Profile: the AMORIS cohort. Int J Epidemiol. 2017;46:1103–i.

Article  PubMed  Google Scholar 

Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet. 2001;358:2026–33.

Article  PubMed  CAS  Google Scholar 

Talmud PJ, Hawe E, Miller GJ, Humphries SE. Nonfasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men. Arteriosclerosis, thrombosis, and vascular biology 2002;22:1918–23.

Ludvigsson JF, Svedberg P, Olén O, Bruze G, Neovius M. The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research. 2019;34:423– 37.

Tsoupras A, Lordan R, Zabetakis I. Inflammation, not cholesterol, is a cause of Chronic Disease. Nutrients 2018;10.

Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.